Home / BusinessBloombergBusinessBloomberg·Jul 10, 2026·1 min readShionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea DrugApnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBloombergBusinessJul 10, 2026 · 1 minPro Shop's Chad Mumm on 'Full Swing,' Golf in 2026BloombergBloombergBusinessJul 10, 2026 · 1 minGensler: Big Deals a Sign of 'High-Valuation Market'BloombergMexico News DailyBusinessJul 10, 2026 · 1 minVinci Airports eyes more Mexico investment as it braces for slower global growthMexico News DailyBloombergBusinessJul 10, 2026 · 1 minHedge Fund Elliott Builds Stake in Software Firm CCCBloomberg
Mexico News DailyBusinessJul 10, 2026 · 1 minVinci Airports eyes more Mexico investment as it braces for slower global growthMexico News Daily